InMode Ltd
(STU:154)
€
14.98
0.3 (2.04%)
Market Cap: 1.14 Bil
Enterprise Value: 491.41 Mil
PE Ratio: 9.57
PB Ratio: 1.69
GF Score: 82/100 Inmode Ltd at Barclays Global Healthcare Conference Transcript
Mar 15, 2023 / 01:30PM GMT
Release Date Price:
€29.2
(-0.68%)
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst
Good morning, everybody. We'll begin our next session. My name is Matt Miksic. I cover medical devices here in the U.S. at Barclays. I'm very pleased to have with us today, InMode. We've got Yair Malca, Chief Financial Officer; and we've also got Spero. I'm not going to try to pronounce your last name.
Spero Theodorou
InMode Ltd. - Chief Medical Officer
Okay. Theodorou, like Theodore Roosevelt.
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst
Okay. Theodorou, Chief Medical Officer.
Questions & Answers
Matthew Stephan Miksic
Barclays Bank PLC, Research Division - Research Analyst
So I wanted to maybe start with just one of the things about InMode that I think catches a lot of medical device folks a little bit offguard, and you probably answer this question all the time here, is the growth model. I think the first conversation we had and I'm relatively
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot